Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neuropsychology Review
Published in: Neuropsychology Review 4/2015

01-12-2015 | Review

Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease

Authors: S. DeVaughn, E. M. Müller-Oehring, B. Markey, H. M. Brontë-Stewart, T. Schulte

Published in: Neuropsychology Review | Issue 4/2015

Login to get access

Abstract

Recent advances in highly active anti-retroviral therapy (HAART) in their various combinations have dramatically increased the life expectancies of HIV-infected persons. People diagnosed with HIV are living beyond the age of 50 but are experiencing the cumulative effects of HIV infection and aging on brain function. In HIV-infected aging individuals, the potential synergy between immunosenescence and HIV viral loads increases susceptibility to HIV-related brain injury and functional brain network degradation similar to that seen in Parkinson’s disease (PD), the second most common neurodegenerative disorder in the aging population. Although there are clear diagnostic differences in the primary pathology of both diseases, i.e., death of dopamine-generating cells in the substantia nigra in PD and neuroinflammation in HIV, neurotoxicity to dopaminergic terminals in the basal ganglia (BG) has been implied in the pathogenesis of HIV and neuroinflammation in the pathogenesis of PD. Similar to PD, HIV infection affects structures of the BG, which are part of interconnected circuits including mesocorticolimbic pathways linking brainstem nuclei to BG and cortices subserving attention, cognitive control, and motor functions. The present review discusses the combined effects of aging and neuroinflammation in HIV individuals on cognition and motor function in comparison with age-related neurodegenerative processes in PD. Despite the many challenges, some HIV patients manage to age successfully, most likely by redistribution of neural network resources to enhance function, as occurs in healthy elderly; such compensation could be curtailed by emerging PD.
Literature
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003a). Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology, 60(3), 387–392.PubMedCrossRef
Aarsland, D., Hutchinson, M., & Larsen, J. P. (2003b). Cognitive, psychiatric and motor response to galantamine in Parkinson’s disease with dementia. International Journal of Geriatric Psychiatry, 18(10), 937–941.PubMedCrossRef
Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 20(10), 1255–1263.CrossRef
Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., … & Emre, M. (2010). Mild cognitive impairment in Parkinson disease A multicenter pooled analysis. Neurology, 75(12), 1062–1069.
Albin, R. L., Young, A. B., & Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends in Neurosciences, 12(10), 366–375.PubMedCrossRef
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357–358.PubMedCrossRef
American Academy of Neurology AIDS Task Force. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41(6), 778–785.CrossRef
Ances, B. M., Ortega, M., Vaida, F., Heaps, J., & Paul, R. (2012). Independent effects of HIV, aging, and HAART on brain volumetric measures. Journal of Acquired Immune Deficiency Syndromes, 59(5), 469.PubMedCentralPubMedCrossRef
Antinori, A., Arendt, G., Becker, J.T., Brew, B.J., Byrd, D.A., Cherner, M., … & Wojna, V.E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799.
Arendt, G., Hefter, H., Elsing, C., Strohmeyer, G., & Freund, H. J. (1990). Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. Journal of Neurology, 237(6), 362–368.PubMedCrossRef
Arruda, J.E., Lacerda, H., Moura, L., Albuquerque, M.F., Miranda, F.D.B., Diniz, G., … & Monteiro, V. (2010). Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. The Brazilian Journal of Infectious Diseases: an Official Publication of the Brazilian Society of Infectious Diseases, 14(3), 281–287.
Aylward, E. H., Henderer, J. D., McArthur, J. C., Brettschneider, P. D., Harris, G. J., Barta, P. E., & Pearlson, G. D. (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology, 43(10), 2099–2104.PubMedCrossRef
Becker, J., & Snitz, B. (2013). Yes, it is time to reconsider how we rate cognitive impairments in HIV disease. Neuroepidemiology, 41(3–4), 217–218.PubMedCrossRef
Berger, J. R., & Arendt, G. (2000). HIV dementia: the role of the basal ganglia and dopaminergic systems. Journal of Psychopharmacology, 14(3), 214–221.PubMedCrossRef
Berger, J. R., & Nath, A. (1997). HIV dementia and the basal ganglia. Intervirology, 40(2–3), 122–131.PubMedCrossRef
Berger, J. R., Kumar, M., Kumar, A., Fernandez, J. B., & Levin, B. (1994). Cerebrospinal fluid dopamine in HIV-1 infection. AIDS, 8(1), 67–71.PubMedCrossRef
Bernard, C., Dilharreguy, B., Allard, M., Amieva, H., Bonnet, F., Dauchy, F., Greib, C., Dehail, P., & Catheline, G. (2013). Muscular weakness in individuals with HIV associated with a disorganization of the cortico-spinal tract: a multi-modal MRI investigation. PLoS One, 8(7), e66810.PubMedCentralPubMedCrossRef
Beste, C., Willemssen, R., Saft, C., & Falkenstein, M. (2010). Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. Neuropsychologia, 48(2), 366–373.PubMedCrossRef
Betchen, S. A., & Kaplitt, M. (2003). Future and current surgical therapies in Parkinson’s disease. Current Opinion in Neurology, 16(4), 487–493.PubMed
Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., Phillips, A., Porter, K., & CASCADE Collaboration. (2008). Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Annals of Neurology, 63(2), 213–221.PubMedCrossRef
Bhidayariri, R., & Tarsy, D. (2012). HIV-induced parkinsonism. Movement disorders – a video atlas. In D. Tarsy (Ed.), Current clinical neurology (pp. 44–45). NY: Springer.
Brew, B. J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(1), 75–78.CrossRef
Brew, B. J., Crowe, S. M., Landay, A., Cysique, L. A., & Guillemin, G. (2009). Neurodegeneration and ageing in the HAART era. Journal of Neuroimmune Pharmacology, 4(2), 163–174.PubMedCrossRef
Buchbinder, S. P., Katz, M. H., Hessol, N. A., O’Malley, P. M., & Holmberg, S. D. (1994). Long-term HIV-1 infection without immunologic progression. AIDS, 8(8), 1123–1128.PubMedCrossRef
Burt, T. D., Agan, B. K., Marconi, V. C., He, W., Kulkarni, H., Mold, J. E., Cavrois, M., Huang, Y., Mahley, R. W., Dolan, M. J., McCune, J. M., & Ahuja, S. K. (2008). Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proceedings of the National Academy of Sciences of the United States of America, 105(25), 8718–8723.PubMedCentralPubMedCrossRef
Caballol, N., Martí, M. J., & Tolosa, E. (2007). Cognitive dysfunction and dementia in Parkinson disease. Movement Disorders, 22(S17), S358–S366.PubMedCrossRef
Cabeza, R., Anderson, N. D., Locantore, J. K., & McIntosh, A. R. (2002). Aging gracefully: compensatory brain activity in high-performing older adults. NeuroImage, 17(3), 1394–1402.PubMedCrossRef
Castellon, S. A., Hinkin, C. H., & Myers, H. F. (2000). Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society, 6(3), 336–347.PubMedCrossRef
Cattie, J. E., Doyle, K., Weber, E., Grant, I., Woods, S. P., & the HIV Neurobehavioral Research Program (HNRP), G. (2012). Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. Journal of Clinical and Experimental Neuropsychology, 34(9), 906–918. doi:10.​1080/​13803395.​2012.​692772.PubMedCentralPubMedCrossRef
Chang, L., Speck, O., Miller, E.N., Braun, J., Jovicich, J., Koch, C., et al. (2001). Neural correlates of attention and working memory deficits in HIV patients. Neurology, 57(6), 1001–1007.
Chang, L., Ernst, T., Witt, M. D., Ames, N., Gaiefsky, M., & Miller, E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients. NeuroImage, 17(3), 1638–1648.PubMedCrossRef
Chang, L., Holt, J. L., Yakupov, R., Jiang, C. S., & Ernst, T. (2013). Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiology of Aging, 34(4), 1240–1253.PubMedCentralPubMedCrossRef
Chang, L., Jiang, C., Cunningham, E., Buchthal, S., Douet, V., Andres, M., & Ernst, T. (2014). Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits. Neurology, 82(24), 2213–2222.PubMedCentralPubMedCrossRef
Cheng, Y. W., Lin, C. H., & Wu, R. M. (2014). HIV-associated parkinsonism reversed with antiretroviral therapy. Neurology Asia, 19(2), 199–203.
Chiappini, F., Teicher, E., Saffroy, R., Pham, P., Falissard, B., Barrier, A., Chevalier, S., Debuire, B., Vittecoq, D., & Lemoine, A. (2004). Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients. Laboratory Investigation, 84(7), 908–914.PubMedCrossRef
Chow, F. C. (2014). HIV infection, vascular disease, and stroke. Seminars in Neurology, 34(1), 35–46.PubMedCrossRef
Chung, Y., Kim, S., & Jin, B. (2010). Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson’s disease. Journal of Immunology, 185(2), 1230–1237.CrossRef
Cohen, R. A., Seider, T. R., & Navia, B. (2015). HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimer’s Research & Therapy, 7(1), 37.CrossRef
Collier, T. J., Kanaan, N. M., & Kordower, J. H. (2011). Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nature Reviews Neuroscience, 12(6), 359–366.PubMedCentralPubMedCrossRef
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012). Contributions of central and systemic inflammation to the pathophysiology of Parkinson’s disease. Neuropharmacology, 62(7), 2154–2168.PubMedCrossRef
Cooper, J. A., Sagar, H. J., Jordan, N., Harvey, N. S., & Sullivan, E. V. (1991). Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability. Brain, 114(5), 2095–2122.PubMedCrossRef
Cooper, J. A., Sagar, H. J., Doherty, S. M., Jordan, N., Tidswell, P., & Sullivan, E. V. (1992). Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson’s disease. A follow-up study of untreated patients. Brain, 115(Pt 6), 1701–1725.PubMedCrossRef
Cooper, J. A., Sagar, H. J., Tidswell, P., & Jordan, N. (1994). Slowed central processing in simple and go/no-go reaction time tasks in Parkinson’s disease. Brain, 117(3), 517–29.PubMedCrossRef
Crum, N.F., Riffenburgh, R.H., Wegner, S., Agan, B.K., Tasker, S.A., Spooner, K.M., … Triservice AIDS Clinical Consortium. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194–200.
Csuka, M., & McCarty, D. J. (1985). Simple method for measurement of lower extremity muscle strength. The American Journal of Medicine, 78(1), 77–81.PubMedCrossRef
Cysique, L. A., Maruff, P., & Brew, B. J. (2006). The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. Journal of the International Neuropsychological Society: JINS, 12(3), 368–382.PubMedCrossRef
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999). The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain, 122(8), 1437–1448.PubMedCrossRef
De Chiara, G., Marcocci, M. E., Sgarbanti, R., Civitelli, L., Ripoli, C., Piacentini, R., Garaci, E., Grassi, C., & Palamara, A. T. (2012). Infectious agents and neurodegeneration. Molecular Neurobiology, 46(3), 614–638.PubMedCentralPubMedCrossRef
de Lau, L. M., & Breteler, M. M. (2006). Epidemiology of Parkinson’s disease. The Lancet Neurology, 5(6), 525–535.PubMedCrossRef
Di Carlo, P., Immordino, P., Mazzola, G., Colletti, P., Alongi, I., Mineo, M., Scognamillo, M., Vitale, F., & Casuccio, A. (2014). Determinants of HIV outpatient service utilization according to HIV parameters. Journal of the International AIDS Society, 17(4 Suppl 3), 19611.PubMedCentralPubMed
Dore, G. J., McDonald, A., Li, Y., Kaldor, J. M., & Brew, B. J. (2003). Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17, 1539–1545.PubMedCrossRef
Doyle, K.L., Morgan, E.E., Morris, S., Smith, D.M., Little, S., Iudicello, J.E., … & Translational Methamphetamine AIDS Research Center (TMARC) Group. (2013). Real-world impact of neurocognitive deficits in acute and early HIV infection. Journal of Neurovirology, 19(6), 565–573.
Dubois, B., & Pillon, B. (1997). Cognitive deficits in Parkinson’s disease. Journal of Neurology, 244(1), 2–8.PubMedCrossRef
du Plessis, S., Vink, M., Joska, J. A., Koutsilieri, E., Bagadia, A., Stein, D. J., & Emsley, R. (2015). HIV infection is associated with impaired striatal function during inhibition with normal cortical functioning on functional MRI. Journal of the International Neuropsychological Society: JINS, 21(9), 722–731.PubMedCrossRef
Ellis, R.J., Badiee, J., Vaida, F., Letendre, S., Heaton, R.K., Clifford, D., … & Grant, I. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (London, England), 25(14).
Farooqui, T., & Farooqui, A. A. (2009). Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mechanisms of Ageing and Development, 130(4), 203–215.PubMedCrossRef
Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., … & van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA, 278(16), 1349–1356.
Gago, M. F., Rosas, M. J., Linhares, P., Massano, J., Sarmento, A., & Vaz, R. (2011). Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease in a patient with HIV infection: Dual clinical benefit. Case Reports in Neurology, 3(3), 219.PubMedCentralPubMedCrossRef
Gaig, C., & Tolosa, E. (2009). When does Parkinson’s disease begin? Movement Disorders, 24(2), 656–664.CrossRef
Galtier, I., Nieto, A., Lorenzo, J. N., & Barroso, J. (2014). Cognitive impairment in Parkinson’s disease: more than a frontostriatal dysfunction. The Spanish Journal of Psychology, 17, E68.PubMedCrossRef
Gasca-Salas, C., Estanga, A., Clavero, P., Aguilar-Palacio, I., González-Redondo, R., Obeso, J. A., & Rodríguez-Oroz, M. C. (2014). Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson’s disease. Journal of Parkinson’s Disease, 4(4), 677–686.PubMed
Gelbard, H. A., Dewhurst, S., Maggirwar, S. B., Kiebala, M., Polesskaya, O., & Gendelman, H. E. (2010). Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase. Neurotherapeutics, 7(4), 392–398.PubMedCentralPubMedCrossRef
Geurtsen, G. J., Hoogland, J., Goldman, J. G., Schmand, B. A., Tröster, A. I., Burn, D. J., Litvan, I., & MDS Study Group on the Validation of PD-MCI Criteria. (2014). Parkinson’s disease mild cognitive impairment: application and validation of the criteria. Journal of Parkinson’s Disease, 4(2), 131–137.PubMedCentralPubMed
Grant, I., Atkinson, J. H., Hesselink, J. R., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J. A. (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Annals of Internal Medicine, 107(6), 828–836.PubMedCrossRef
Granziera, C., Daducci, A., Simioni, S., Cavassini, M., Roche, A., Meskaldji, D., Kober, T., Metral, M., Calmy, A., Helms, G., Hirschel, B., Lazeyras, F., Meuli, R., Krueger, G., & Du Pasquier, R. A. (2013). Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field. PLoS One, 8(9), e72547.PubMedCentralPubMedCrossRef
Greene, M., Justice, A. C., Lampiris, H. W., & Valcour, V. (2013). Management of human immunodeficiency virus infection in advanced age. JAMA, 309(13), 1397–1405.PubMedCentralPubMedCrossRef
Groome, D., & Baker, K. L. (2005). An introduction to applied cognitive psychology. In A. Esgate (Ed.). Psychology Press.
Haber, S. N., & Calzavara, R. (2009). The cortico-basal ganglia integrative network: the role of the thalamus. Brain Research Bulletin, 78(2), 69–74.PubMedCentralPubMedCrossRef
Haddow, L. J., Floyd, S., Copas, A., & Gilson, R. J. (2013). A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PloS One, 8(4), e61826.PubMedCentralPubMedCrossRef
Hakun, J. G., Zhu, Z., Johnson, N. F., & Gold, B. T. (2015). Evidence for reduced efficiency and successful compensation in older adults during task switching. Cortex, 64, 352–362.PubMedCrossRef
Harezlak, J., Buchthal, S., Taylor, M., Schifitto, G., Zhong, J., Daar, E., … & HIV Neuroimaging Consortium. (2011). Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS, 25(5), 625–633.
Harper, S. J., & Wilkie, N. (2003). MAPKs: new targets for neurodegeneration. Expert Opinion on Therapeutic Targets, 7, 187–200.PubMedCrossRef
Hayman, M., Arbuthnott, G., Harkiss, G., Brace, H., Filippi, P., Philippon, V., Thomson, D., Vigne, R., & Wright, A. (1993). Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience, 53(1), 1–6.PubMedCrossRef
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995). The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society: JINS, 1(3), 231–251.PubMedCrossRef
Heaton, R. K., Clifford, D. B., Franklin, D. R., Jr., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096.PubMedCentralPubMedCrossRef
Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., Woods, S. P., Collier, A. C., Marra, C. M., Morgello, S., Mindt, M. R., Taylor, M. J., Marcotte, T. D., Atkinson, J. H., Wolfson, T., Gelman, B. B., McArthur, J. C., Simpson, D. M., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & CHARTER Group; HNRC Group. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16.PubMedCentralPubMedCrossRef
Heaton, R. K., Franklin, D. R., Jr., Deutsch, R., Letendre, S., Ellis, R. J., Casaletto, K., Marquine, M. J., Woods, S. P., Vaida, F., Atkinson, J. H., Marcotte, T. D., McCutchan, J. A., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., Sacktor, N., Morgello, S., Simpson, D. M., Abramson, I., Gamst, A. C., Fennema-Notestine, C., Smith, D. M., Grant, I., & CHARTER Group. (2015). Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clinical Infectious Diseases, 60(3), 473–480.PubMedCrossRef
Helmrich, R., Derikx, L., Bakker, M., Scheeringa, R., Bloem, B., & Toni, I. (2010). Spatial remapping of cortico-striatal connectivity in Parkinson’s disease. Cerebral Cortex, 20(5), 1175–1186.CrossRef
Hersh, B. P., Rajendran, P. R., & Battinelli, D. (2001). Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology, 56(2), 278–279.PubMedCrossRef
Hettige, S., Samuel, M., Clough, C., Hulse, N., & Ashkan, K. (2009). Deep brain stimulation for Parkinson’s disease when HIV coexists. Movement Disorders, 24(14), 2169–2171.PubMedCrossRef
Hindle, J. V., Martyr, A., & Clare, L. (2014). Cognitive reserve in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism & Related Disorders, 20(1), 1–7.CrossRef
Hinkin, C. H., Castellon, S. A., Hardy, D. J., Granholm, E., & Siegle, G. (1999). Computerized and traditional stroop task dysfunction in HIV-1 infection. Neuropsychology, 13(2), 306–316.PubMedCrossRef
Hinkin, C. H., Castellon, S. A., & Hardy, D. J. (2000). Dual task performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 22(1), 16–24.PubMedCrossRef
Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson’s disease: a target for neuroprotection? The Lancet Neurology, 8(4), 382–397.PubMedCrossRef
Hobson, P., & Meara, J. (2015). Mild cognitive impairment in Parkinson’s disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. International Journal of Geriatric Psychiatry.
Hoehn, M. M., & Yahr, M. D. (1998). Parkinsonism: onset, progression, and mortality. Neurology, 50(2), 318–318.PubMedCrossRef
Hofman, F. M., Dohadwala, M. M., Wright, A. D., Hinton, D. R., & Walker, S. M. (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. Journal of Neuroimmunology, 54(1–2), 19–28.PubMedCrossRef
Ipser, J. C., Brown, G. G., Bischoff-Grethe, A., Connolly, C. G., Ellis, R. J., Heaton, R. K., & Grant, I. (2015). HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. Journal of the International Neuropsychological Society, 21(3), 203–213.PubMedCentralPubMedCrossRef
Ishihara, L. S., Cheesbrough, A., Brayne, C., & Schrag, A. (2007). Estimated life expectancy of Parkinson’s patients compared with the UK population. Journal of Neurology, Neurosurgery & Psychiatry, 78(12), 1304–1309.CrossRef
Itoh, K., Mehraein, P., & Weis, S. (2000). Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathologica, 99(4), 376–384.PubMedCrossRef
Jacobs, M. M., Murray, J., Byrd, D. A., Hurd, Y. L., & Morgello, S. (2013). HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations. Journal of Neurovirology, 19(5), 495–504.PubMedCrossRef
Jahanshad, N., Valcour, V. G., Nir, T. M., Kohannim, O., Busovaca, E., Nicolas, K., & Thompson, P. M. (2012). Disrupted brain networks in the aging HIV+ population. Brain Connectivity, 2(6), 335–344.PubMedCentralPubMedCrossRef
Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79(4), 368–376.CrossRef
Johnson, G. V., & Bailey, C. D. (2003). The p38 MAP kinase signaling pathway in Alzheimer’s disease. Experimental Neurology, 183, 263–268.PubMedCrossRef
Jokinen, P., Karrasch, M., Brück, A., Johansson, J., Bergman, J., & Rinne, J. O. (2013). Cognitive slowing in Parkinson’s disease is related to frontostriatal dopaminergic dysfunction. Journal of the Neurological Sciences, 329(1–2), 23–8.PubMedCrossRef
Jones, M., Olafson, K., Del Bigio, M. R., Peeling, J., & Nath, A. (1998). Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. Journal of Neuropathology and Experimental Neurology, 57(6), 563–570.PubMedCrossRef
Kernutt, G. J., Price, A. J., Judd, F. K., & Burrows, G. D. (1993). Human immunodeficiency virus infection, dementia and the older patient. Australian and New Zealand Journal of Psychiatry, 27(1), 9–19.PubMedCrossRef
Khanlou, N., Moore, D.J., Chana, G., Cherner, M., Lazzaretto, D., Dawes, S., & … Everall, I.P. (2009). Increased frequency of α-synuclein in the substantia nigra in human immunodeficiency virus infection. Journal Of Neurovirology, 15(2), 131–138. doi:10.​1080/​1355028080257807​5.
Kim, J. W., Cheon, S. M., Park, M. J., Kim, S. Y., & Jo, H. Y. (2009). Cognitive impairment in Parkinson’s disease without dementia: subtypes and influences of age. Journal of Clinical Neurology, 5(3), 133–138.PubMedCentralPubMedCrossRef
Kingstone, A., Klein, R., Morein-Zamir, S., Hunt, A., Fisk, J., & Maxner, C. (2002). Orienting attention in aging and Parkinson’s disease: distinguishing modes of control. Journal of Clinical and Experimental Neuropsychology, 24(7), 951–967.PubMedCrossRef
Kobylecki, C., Silverdale, M. A., Varma, A., Dick, J. P., & Kellett, M. W. (2009). HIV‐associated parkinsonism with levodopa‐induced dyskinesia and response to highly‐active antiretroviral therapy. Movement Disorders, 24(16), 2441–2442.PubMed
Konczak, J., Corcos, D.M., Horak, F., Poizner, H., Shapiro, M., Tuite, P., & … Maschke, M. (2009). Proprioception and Motor Control in Parkinson’s Disease. Journal Of Motor Behavior, 41(6), 543–552.
Koski, L., Brouillette, M. J., Lalonde, R., Hello, B., Wong, E., Tsuchida, A., & Fellows, L. K. (2011). Computerized testing augments pencil‐and‐paper tasks in measuring HIV‐associated mild cognitive impairment. HIV Medicine, 12(8), 472–480.PubMedCrossRef
Koutsilieri, E., Sopper, S., Scheller, C., ter Meulen, V., & Riederer, P. (2002). Parkinsonism in HIV dementia. Journal of Neural Transmission, 109(5–6), 767–775.PubMedCrossRef
Kruman, I. I., Nath, A., Maragos, W. F., Chan, S. L., Jones, M., Rangnekar, V. M., Jakel, R. J., & Mattson, M. P. (1999). Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. The American Journal of Pathology, 155(1), 39–46.PubMedCentralPubMedCrossRef
Kuhlmann, I., Minihane, A. M., Huebbe, P., Nebel, A., & Rimbach, G. (2010). Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids in Health and Disease, 9, 8.PubMedCentralPubMedCrossRef
Kumar, A. M., Fernandez, J. B., Singer, E. J., Commins, D., Waldrop-Valverde, D., Ownby, R. L., & Kumar, M. (2009). Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. Journal of Neurovirology, 15(3), 257–274.PubMedCrossRef
Kumar, A. M., Ownby, R. L., Waldrop-Valverde, D., Fernandez, B., & Kumar, M. (2011). Human immunodeficiency virus infection in the CNS and decreased dopamine availability: Relationship with neuropsychological performance. Journal of Neurovirology, 17(1), 26–40.PubMedCrossRef
Langford, D., Baron, D., Joy, J., Del Valle, L., & Shack, J. (2011). Contributions of HIV infection in the hypothalamus and substance abuse /use to HPT dysregulation. Psychoneuroendocrinology, 36(5), 710–719.PubMedCentralPubMedCrossRef
Lehéricy, S., Benali, H., Van de Moortele, P. F., Pélégrini-Issac, M., Waechter, T., Ugurbil, K., & Doyon, J. (2005). Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proceedings of the National Academy of Sciences of the United States of America, 102(35), 12566–12571.PubMedCentralPubMedCrossRef
Lewis, S. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003). Cognitive impairments in early Parkinson’s disease are accompanied by reductions in activity in frontostriatal neural circuitry. The Journal of Neuroscience, 23(15), 6351–6356.PubMed
Lewis, S. J., Slabosz, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2005). Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson’s disease. Neuropsychologia, 43(6), 823–832.PubMedCrossRef
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.PubMedCentralPubMedCrossRef
Louboutin, J. P., Agrawal, L., Reyes, B. A., Van Bockstaele, E. J., & Strayer, D. S. (2009). HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: Protection by rSV40 delivery of antioxidant enzymes. Neurobiology of Disease, 34(3), 462–476.PubMedCrossRef
Malaspina, L., Woods, S., Moore, D., Depp, C., Letendre, S., Jeste, D., & Grant, I. (2011). Successful cognitive aging in persons living with HIV infection. Journal of Neurovirology, 17(1), 110–119.PubMedCentralPubMedCrossRef
Mallol, R., Barrós-Loscertales, A., López, M., Belloch, V., Parcet, M. A., & Ávila, C. (2007). Compensatory cortical mechanisms in Parkinson’s disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Research, 1147, 265–271.PubMedCrossRef
Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., et al. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. Journal of the International Neuropsychological Society, 5, 579–592.PubMedCrossRef
Martin, E. M., Pitrak, D. L., Robertson, L. C., Novak, R. M., Mullane, K. M., & Pursell, K. J. (1995). Global-local analysis in HIV-1 infection. Neuropsychology, 9(1), 102–109.CrossRef
Martins, R., Joanette, Y., & Monchi, O. (2015). The implications of age-related neurofunctional compensatory mechanisms in executive function and language processing including the new Temporal Hypothesis for Compensation. Frontiers in Human Neuroscience, 9.
Maruff, P., Currie, J., Malone, V., McArthur-Jackson, C., Mulhall, B., & Benson, E. (1994). Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery. Archives of Neurology, 51(7), 689–695.PubMedCrossRef
Mateen, F., Kanters, S., Kalyesubula, R., Mukasa, B., Kawuma, E., Kenge, A., & Mills, E. (2013). Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. Journal of Hypertension, 31(7), 1372–1378.PubMedCrossRef
Mattay, V.S., Tessitore, A., Callicott, J.H., Bertolino, A., Goldberg, T.E., Chase, T.N., & … Weinberger, D.R. (2002). Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Annals of Neurology, 51(2), 156–164. doi:10.​1002/​ana.​10078.
McArthur, J. C., & Brew, B. J. (2010). HIV-associated neurocognitive disorders: Is there a hidden epidemic? AIDS, 24(9), 1367–1370.PubMedCrossRef
McFarland, N. R., & Haber, S. N. (2002). Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. The Journal of Neuroscience, 22(18), 8117–8132.PubMed
McKinlay, A., Grace, R. C., Dalrymple-Alford, J. C., & Roger, D. (2010). Characteristics of executive function impairment in Parkinson’s disease patients without dementia. Journal of the International Neuropsychological Society, 16(02), 268–277.PubMedCrossRef
Mekker, A., Tchang, V. S., Haeberli, L., Oxenius, A., Trkola, A., & Karrer, U. (2012). Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathogens, 8(8), e1002850.PubMedCentralPubMedCrossRef
Melrose, R. J., Tinaz, S., Castelo, J. B., Courtney, M. G., & Stern, C. E. (2008). Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behavioural Brain Research, 188(2), 337–347.PubMedCrossRef
Mink, J. W. (1996). The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology, 50(4), 381–425.PubMedCrossRef
Mirsattari, S. M., Power, C., & Nath, A. (1998). Parkinsonism with HIV infection. Movement Disorders, 13(4), 684–689.PubMedCrossRef
Monchi, O., Petrides, M., Doyon, J., Postuma, R. B., Worsley, K., & Dagher, A. (2004). Neural bases of set-shifting deficits in Parkinson’s disease. Journal of Neuroscience, 24(3), 702–710.PubMedCrossRef
Monchi, O., Petrides, M., Strafella, A. P., Worsley, K. J., & Doyon, J. (2006). Functional role of the basal ganglia in the planning and execution of actions. Annals of Neurology, 59(2), 257–264.PubMedCrossRef
Monchi, O., Petrides, M., Mejia-Constain, B., & Strafella, A. P. (2007). Cortical activity in Parkinson’s disease during executive processing depends on striatal involvement. Brain, 130, 233–244.PubMedCentralPubMedCrossRef
Moore, R., Moore, D., Thompson, W., Vahia, I., Grant, I., & Jeste, D. (2013). A case-controlled study of successful aging in older HIV-infected adults. The Journal of Clinical Psychiatry, 74(5), 417–423.CrossRef
Morgan, E.E., Woods, S.P., & Grant, I. (2012). Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders. Archives of Clinical Neuropsychology.
Morgan, E. E., Woods, S. P., Letendre, S. L., Franklin, D. R., Bloss, C., Goate, A., Heaton, R. K., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Ellis, R. J., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D. M., Grant, I., Vaida, F., Clifford, D. B., & CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group. (2013). Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. Journal of Neurovirology, 19(2), 150–156.PubMedCentralPubMedCrossRef
Mosley, R. L., Hutter-Saunders, J. A., Stone, D. K., & Gendelman, H. E. (2012). Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harbor Perspectives in Medicine, 2(1), a009381.PubMedCentralPubMedCrossRef
Moulignier, A., Gueguen, A., Lescure, F. X., Ziegler, M., Girard, P. M., Cardon, B., Pialoux, G., Molina, J. M., Brandel, J. P., & Lamirel, C. (2015). Does HIV infection alter Parkinson disease? Journal of Acquired Immune Deficiency Syndromes, 70(2), 129–36.PubMedCrossRef
Müller-Oehring, E.M., Sullivan, E.V., Pfefferbaum, A., Huang, N.C., Poston, K.L., Bronte-Stewart, H.M., & Schulte, T. (2014). Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s disease. Brain Imaging and Behavior, 1–20.
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239–1245.PubMedCrossRef
Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., & Geiger, J. D. (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Annals of Neurology, 47(2), 186–194.PubMedCrossRef
Navia, B. A., Jordan, B. D., & Price, R. W. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19(6), 517–524.PubMedCrossRef
Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014). Controversies in HIV-associated neurocognitive disorders. The Lancet Neurology, 13(11), 1139–1151.PubMedCentralPubMedCrossRef
Olesen, P. J., Schendan, H. E., Amick, M. M., & Cronin-Golomb, A. (2007). HIV infection affects parietal-dependent spatial cognition: evidence from mental rotation and hierarchical pattern perception. Behavioral Neuroscience, 121(6), 1163–1173.PubMedCrossRef
Oliveira, R. M., Gurd, J. M., Nixon, P., Marshall, J. C., & Passingham, R. E. (1997). Micrographia in Parkinson’s disease: the effect of providing external cues. Journal Of Neurology, Neurosurgery & Psychiatry, 63(4), 429–433.CrossRef
Pahwa, R., & Lyons, K. E. (2009). Levodopa-related wearing-off in Parkinson’s disease: Identification and management. Current Medical Research and Opinion, 25(4), 841–849.PubMedCrossRef
Pahwa, R., Paolo, A., Troster, A., & Koller, W. (1998). Cognitive impairment in Parkinson’s disease. European Journal of Neurology, 5(5), 431–441.PubMedCrossRef
Parent, A., & Hazrati, L. N. (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Research. Brain Research Reviews, 20(1), 91–127.PubMedCrossRef
Pereyra, F., Addo, M. M., Kaufmann, D. E., Liu, Y., Miura, T., Rathod, A., Baker, B., Trocha, A., Rosenberg, R., Mackey, E., Ueda, P., Lu, Z., Cohen, D., Wrin, T., Petropoulos, C. J., Rosenberg, E. S., & Walker, B. D. (2008). Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. The Journal of Infectious Diseases, 197(4), 563–571.PubMedCrossRef
Pfefferbaum, A., Rosenbloom, M. J., Rohlfing, T., Kemper, C. A., Deresinski, S., & Sullivan, E. V. (2009). Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS, 23(15), 1977–1985.PubMedCentralPubMedCrossRef
Pfefferbaum, A., Rosenbloom, M. J., Sassoon, S. A., Kemper, C. A., Deresinski, S., Rohlfing, T., & Sullivan, E. V. (2012). Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biological Psychiatry, 72(5), 361–370.PubMedCentralPubMedCrossRef
Pfefferbaum, A., Rogosa, D. A., Rosenbloom, M. J., Chu, W., Sassoon, S. A., Kemper, C. A., Deresinski, S., Rohlfing, T., Zahr, N. M., & Sullivan, E. V. (2014). Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiology of Aging, 35(7), 1755–1768.PubMedCentralPubMedCrossRef
Poletti, M., Baldacci, F., Nuti, A., Lucetti, C., Berti, C., & Bonuccelli, U. (2009). Decision-making impairment in a patient with new concomitant diagnoses of Parkinson’s disease and HIV. The Journal of Neuropsychiatry and Clinical Neurosciences, 21(3), 352–353.PubMedCrossRef
Raz, N., Ghisletta, P., Rodrigue, K. M., Kennedy, K. M., & Lindenberger, U. (2010). Trajectories of brain aging in middle-aged and older adults: regional and individual differences. NeuroImage, 51(2), 501–511.PubMedCentralPubMedCrossRef
Richards, M., & Deary, I. J. (2005). A life course approach to cognitive reserve: a model for cognitive aging and development? Annals of Neurology, 58(4), 617–622.PubMedCrossRef
Richert, L., Brault, M., Mercié, P., Dauchy, F. A., Bruyand, M., Greib, C., Dabis, F., Bonnet, F., Chêne, G., Dehail, P., & Groupe d’Epidémiologie Clinique du SIDA en Aquitaine (GECSA). (2014). Decline in locomotor functions over time in HIV-infected patients. AIDS, 10, 1441–1449.CrossRef
Robertson, K. R., Parsons, T. D., Sidtis, J. T., Hanlon Inman, T., Robertson, W. T., Hall, C. D., & Price, R. W. (2006). Timed gait test: normative data for the assessment of the AIDS dementia complex. Journal of Clinical and Experimental Neuropsychology, 28(7), 1053–1064.PubMedCrossRef
Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J., … & Ellis, R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915–1921.
Royall, D. R., Cordes, J. A., & Polk, M. (1998). CLOX: an executive clock drawing task. Journal of Neurology, Neurosurgery & Psychiatry, 64(5), 588–594.CrossRef
Sadek, J. R., Johnson, S. A., White, D. A., Salmon, D. P., Taylor, K. I., DeLaPena, J. H., Paulsen, J. S., Heaton, R. K., & Grant, I. (2004). Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer’s disease, and Huntington’s disease. Neuropsychology, 18(4), 692.PubMedCrossRef
Sadigh-Eteghad, S., Talebi, M., & Farhoudi, M. (2012). Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease. A meta-analysis. Neurosciences (Riyadh), 17(4), 321–326.
Salmon, D. P., & Filoteo, J. V. (2007). Neuropsychology of cortical versus subcortical dementia syndromes. Seminars in Neurology, 27(1), 7–21.PubMedCrossRef
Satz, P., Morgenstern, H., Miller, E. N., Selnes, O. A., McArthur, J. C., Cohen, B. A., Wesch, J., Becker, J. T., Jacobson, L., D’Elia, L. F., et al. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndromes, 6(5), 503–511.PubMedCrossRef
Satz, P., Cole, M. A., Hardy, D. J., & Rassovsky, Y. (2011). Brain and cognitive reserve: mediator(s) and construct validity, a critique. Journal of Clinical and Experimental Neuropsychology, 33(1), 121–130.PubMedCrossRef
Schulte, T., Müller-Oehring, E. M., Javitz, H., Pfefferbaum, A., & Sullivan, E. V. (2008). Callosal compromise differentially affects conflict processing and attentional allocation in alcoholism, HIV, and their comorbidity. Brain Imaging and Behavior, 2(1), 27–38.PubMedCentralPubMedCrossRef
Schulte, T., Müller-Oehring, E. M., Chanraud, S., Rosenbloom, M., Pfefferbaum, A., & Sullivan, E. V. (2011). Age-related reorganization of functional networks for successful conflict resolution: a combined functional and structural MRI study. Neurobiology of Aging, 32(11), 2075–2090.PubMedCentralPubMedCrossRef
Schulte, T., Müller-Oehring, E. M., Sullivan, E. V., & Pfefferbaum, A. (2012). White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia, 50(12), 2812–2822.PubMedCentralPubMedCrossRef
Schulte, T., Pfefferbaum, A., Jung, Y. C., Sullivan, E. V., Huang, N. C., Hawkes, W. C., & Müller-Oehring, E. M. (2013). Striatal intrinsic functional connectivity in HIV and Parkinson Disease. Journal of the International Neuropsychological Society, 19(Supplement S1), 286.
Sheppard, D.P., Iudicello, J.E., Bondi, M.W., Doyle, K.L., Morgan, E.E., Massman, P.J., Gilbert, P.E., & Woods, S.P. (2015). Elevated rates of mild cognitive impairment in HIV disease. Journal for Neurovirology.
Shimohata, T., Takadou, Y., Terajima, K., Tsukada, H., Gejo, F., Tanaka, K., & Nishizawa, M. (2006). A patient with HIV encephalopathy presenting with parkinsonism during HAART therapy. Nō to Shinkei = Brain and Nerve, 58(6), 495–499.PubMed
Smith, R. L., de Boer, R., Brul, S., Budovskaya, Y., & van Spek, H. (2013). Premature and accelerated aging: HIV or HAART? Frontiers in Genetics, 3, 328.PubMedCentralPubMedCrossRef
Spetsieris, P. G., Ko, J. H., Tang, C. C., Nazem, A., Sako, W., Peng, S., Ma, Y., Dhawan, V., & Eidelberg, D. (2015). Metabolic resting-state brain networks in health and disease. Proceedings of the National Academy of Sciences of the United States of America, 112(8), 2563–2568.PubMedCentralPubMedCrossRef
Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society JINS, 8(3), 448–460.PubMedCrossRef
Stern, Y., Habeck, C., Moeller, J., Scarmeas, N., Anderson, K.E., Hilton, H.J., . . . & van Heertum, R. (2005). Brain networks associated with cognitive reserve in healthy young and old adults. Cerebral Cortex, 15(4), 394–402.
Sullivan, E. V., Rosenbloom, M. J., Rohlfing, T., Kemper, C. A., Deresinski, S., & Pfefferbaum, A. (2011). Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia. Brain Imaging and Behavior, 5(1), 12–24.PubMedCentralPubMedCrossRef
Thomas, J. B., Brier, M. R., Snyder, A. Z., Vaida, F. F., & Ances, B. M. (2013). Pathways to neurodegeneration: Effects of HIV and aging on resting-state functional connectivity. Neurology, 80(13), 1186–1193.PubMedCentralPubMedCrossRef
Tisch, S., & Brew, B. (2009). Parkinsonism in HIV-infected patients on highly active antiretroviral therapy. Neurology, 73(5), 401–403.PubMedCrossRef
Tisch, S., & Brew, B. J. (2010). HIV, HAART, and Parkinson’s disease: Co‐incidence or pathogenetic link? Movement Disorders, 25(13), 2257–2258.PubMedCrossRef
Tommasi, G., Fiorio, M., Yelnik, J., Krack, P., Sala, F., Schmitt, E., Fraix, V., Bertolasi, L., Le Bas, J. F., Ricciardi, G. K., Fiaschi, A., Theeuwes, J., Pollak, P., & Chelazzi, L. (2015). Disentangling the role of cortico-Basal Ganglia loops in top-down and bottom-up visual attention: an investigation of attention deficits in Parkinson disease. Journal of Cognitive Neuroscience, 27(6), 1215–1237.PubMedCrossRef
Tse, W., Cersosimo, M. G., Gracies, J. M., Morgello, S., Olanow, C. W., & Koller, W. (2004). Movement disorders and AIDS: a review. Parkinsonism & Related Disorders, 10(6), 323–334.CrossRef
Turner, M. A., Moran, N. F., & Kopelman, M. D. (2002). Subcortical dementia. The British Journal of Psychiatry, 180(2), 148–151.PubMedCrossRef
Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O.A., … & Sacktor, N. (2004). Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. Journal of Neuroimmunology, 157(1), 197–202.
Valcour, V., Watters, M. R., Williams, A. E., Sacktor, N., McMurtray, A., & Shikuma, C. (2008). Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. Journal of Neurovirology, 14(5), 362–367.PubMedCentralPubMedCrossRef
van Sighem, A., Gras, L., Reiss, P., Brinkman, K., . . . de Wolf, F. (2010). Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS, 24(10), 1527–1535.
von Giesen, H. J., Antke, C., Hefter, H., Wenserski, F., Seitz, R. J., & Arendt, G. (2000). Potential time course of human immunodeficiency virus type 1–associated minor motor deficits: electrophysiologic and positron emission tomography findings. Archives of Neurology, 57(11), 1601–1607.
Vriend, C., Gerrits, N. J., Berendse, H. W., Veltman, D. J., van den Heuvel, O. A., & van der Werf, Y. D. (2015). Failure of stop and go in de novo Parkinson’s disease—a functional magnetic resonance imaging study. Neurobiology of Aging, 36(1), 470–475.PubMedCrossRef
Wang, G., Chang, L., Volkow, N., Telang, F., Logan, J., Ernst, T., & Fowler, J. (2004). Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain, 127(11), 2452–2458.PubMedCrossRef
Watkins, C. C., & Treisman, G. J. (2015). Cognitive impairment in patients with AIDS - prevalence and severity. HIV/AIDS: Research and Palliative Care, 7, 35–47.
Wilson, T. W., Heinrichs-Graham, E., Robertson, K. R., Sandkovsky, U., O’Neill, J., Knott, N. L., Fox, H. S., & Swindells, S. (2013). Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on Neuroimmune Pharmacology, 8(4), 965–974.CrossRef
Wilson, T. W., Heinrichs-Graham, E., Becker, K. M., Aloi, J., Robertson, K. R., Sandkovsky, U., White, M. L., O’Neill, J., Knott, N. L., Fox, H. S., & Swindells, S. (2015). Multimodal neuroimaging evidence of alteration in cortical structure and function in HIV-infected older adults. Human Brain Mapping, 36(3), 897–910.PubMedCrossRef
Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152–168.PubMedCentralPubMedCrossRef
Wu, T., Wang, J., Wang, C., Hallett, M., Zang, Y., Wu, X., & Chan, P. (2012). Basal ganglia circuits changes in Parkinson’s disease patients. Neuroscience Letters, 524(1), 55–59.PubMedCentralPubMedCrossRef
Xu, J., Kao, S. Y., Lee, F. J., Song, W., Jin, L. W., & Yankner, B. A. (2002). Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nature Medicine, 8(6), 600–606.PubMedCrossRef
Yin, H. H., & Knowlton, B. J. (2006). The role of the basal ganglia in habit formation. Nature Reviews Neuroscience, 7(6), 464–476.PubMedCrossRef
Metadata
Title
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease
Authors
S. DeVaughn
E. M. Müller-Oehring
B. Markey
H. M. Brontë-Stewart
T. Schulte
Publication date
01-12-2015
Publisher
Springer US
Published in
Neuropsychology Review / Issue 4/2015
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI
https://doi.org/10.1007/s11065-015-9305-x

Other articles of this Issue 4/2015

Neuropsychology Review 4/2015 Go to the issue

Review

The Subthalamic Nucleus, Limbic Function, and Impulse Control

Editorial

Editor’s Note

Editorial

Neuropsychology Review 2009–2015

Review

High Frequency Deep Brain Stimulation and Neural Rhythms in Parkinson’s Disease

Review

Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease

Review

Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review